1. Zahoor ul Haq Shah, M., V.K. Shrivastava, S. Sofi, Y.F. Jamous, M.F. Khan, F.K. Alkholifi, W. Ahmad and M.A. Mir, 2023. Chlorogenic acid restores ovarian functions in mice with letrozole-induced polycystic ovarian syndrome via modulation of adiponectin receptor. Biomedicines, Vol. 11. 10.3390/biomedicines11030900.
   CrossRef  |  Direct Link  |  
2. Zahoor ul Haq Shah, M., V.K. Shrivastava and M.A. Mir, 2023. Ginger extract ameliorates endocrine-metabolic disturbances in letrozole-induced PCOS mice model by altering androgen-adiponectin status. Obesity Med., Vol. 39. 10.1016/j.obmed.2023.100485.
   CrossRef  |  Direct Link  |  
3. Shah, M.Z.U.H., V.K. Shrivastva, M.A. Mir, W.M. Sheikh and M.A. Ganie et al., 2023. Effect of quercetin on steroidogenesis and folliculogenesis in ovary of mice with experimentally-induced polycystic ovarian syndrome. Front. Endocrinol., Vol. 14. 10.3389/fendo.2023.1153289.
   CrossRef  |  Direct Link  |  
4. Shah, M.Z.U.H., V.K. Shrivastava, M.A. Mir and K.S. Olaniyi, 2023. Role of diacerein on steroidogenesis and folliculogenesis related genes in ovary of letrozole-induced PCOS mice. Chem. Biol. Interact., Vol. 377. 10.1016/j.cbi.2023.110468.
   CrossRef  |  Direct Link  |  
5. Qayoom, H., S. Sofi and M.A. Mir, 2023. Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis. Immunol. Res., 10.1007/s12026-023-09376-2.
   CrossRef  |  Direct Link  |  
6. Mir, M.A., S. Ullah Khan and S. Aisha, 2023. Cell Cycle Dysregulation in Breast Cancer. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer, Singapore, ISBN: 978-981-19-8911-7, pp: 103-131.
   CrossRef  |  Direct Link  |  
7. Mir, M.A., S. Sofi and P.M. Ishfaq, 2023. CDK Dysregulation in Breast Cancer: A Bioinformatics Analysis. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer, Singapore, ISBN: 978-981-19-8911-7, pp: 175-194.
   CrossRef  |  Direct Link  |  
8. Mir, M.A., S. Aisha, K. Fatima and F.A. Malik, 2023. Response of Therapy in Cell-Cycle Regulatory Genes in Breast Cancer. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer Nature Singapore, pp: 335–353.
   CrossRef  |  Direct Link  |  
9. Mir, M.A., H. Qayoom, S. Sofi and N. Jan, 2023. Proteomics: Application of Next-Generation Proteomics in Cancer Research. In: Proteomics: A Promising Approach for Cancer Research, Ali, S., S. Majid and M.U. Rehman (Eds.), Elsevier, pp: 55-76.
   CrossRef  |  Direct Link  |  
10. Mir, M.A., H. Qayoom, S. Sofi and N. Jan, 2023. Proteomics: A Groundbreaking Development in Cancer Biology. In: Proteomics: A Promising Approach for Cancer Research, Ali, S., S. Majid and M.U. Rehman (Eds.), Academic Press, Netherlands, ISBN: 978-0-323-95072-5, pp: 31-53.
    CrossRef  |  Direct Link  |  
11. Mir, M.A., A. Gul, S. Sofi and M.S. Khan, 2023. CDk Inhibitor for Treatment of Breast Cancer. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer Nature, Singapore, ISBN: 978-981-19-8910-0, pp: 313-333.
    CrossRef  |  Direct Link  |  
12. Mir, M.A. and U.Y. Mir, 2023. Targeting CDKs with Other Chemotherapeutic Drugs: A Combinatorial Approach. In: Therapeutic Potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer, Singapore, ISBN: 978-981-19-8911-7, pp: 269–289.
    CrossRef  |  Direct Link  |  
13. Mir, M.A. and U. Jan, 2023. Cdk4/Cdk6 Dysregulation in Estrogen-Positive Receptor Breast Cancers. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer, Singapore, ISBN: 978-981-19-8911-7, pp: 211–232.
    CrossRef  |  Direct Link  |  
14. Mir, M.A. and U. Jan, 2023. CDKs in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer, Singapore, ISBN: 978-981-19-8911-7, pp: 291–311.
    CrossRef  |  Direct Link  |  
15. Mir, M.A. and T. Javeed, 2023. Novel CDK Inhibitors in Breast Cancer. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer, Singapore, ISBN: 978-981-19-8911-7, pp: 253–267.
    CrossRef  |  Direct Link  |  
16. Mir, M.A. and S. Sofi, 2023. Cell Cycle and Cancer. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer, Singapore, ISBN: 978-981-19-8911-7, pp: 83–101.
    CrossRef  |  Direct Link  |  
17. Mir, M.A. and I. Mohi Ud Din, 2023. Molecular Subtypes of Breast Cancer and CDk Dysregulation. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer Nature, Singapore, ISBN: 978-981-19-8910-0, pp: 133–148.
    CrossRef  |  Direct Link  |  
18. Mir, M.A. and H. Qayoom, 2023. Introduction to Breast Cancer. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer, Singapore, ISBN: 978-981-19-8911-7, pp: 1-22.
    CrossRef  |  Direct Link  |  
19. Mir, M.A. and H. Qayoom, 2023. Different Cyclins and Their Significance in Breast Cancer. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer, Singapore, ISBN: 978-981-19-8911-7, pp: 355–373.
    CrossRef  |  Direct Link  |  
20. Mir, M.A. and Burhan Ul Haq, 2023. Therapeutic Implications of CDKs in Breast Cancer. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer, Singapore, ISBN: 978-981-19-8911-7, pp: 233–252.
    CrossRef  |  Direct Link  |  
21. Mir, M.A. and Burhan Ul Haq, 2023. CDK1 Dysregulation in Breast Cancer. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer, Singapore, ISBN: 978-981-19-8911-7, pp: 195-210.
    CrossRef  |  Direct Link  |  
22. Mir, M.A. and A.Y. Mir, 2023. Current Treatment Approaches to Breast Cancer. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer, Singapore, ISBN: 978-981-19-8911-7, pp: 23–51.
    CrossRef  |  Direct Link  |  
23. Mir, M.A. and A.Y. Mir, 2023. Breast Tumor Microenvironment and CDKs. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer, Singapore, ISBN: 978-981-19-8911-7, pp: 149-174.
    CrossRef  |  Direct Link  |  
24. Mir, M.A. and A. Jan, 2023. Introduction to Cell Cycle and Its Regulators. In: Therapeutic potential of Cell Cycle Kinases in Breast Cancer, Mir, M. (Ed.), Springer, Singapore, ISBN: 978-981-19-8911-7, pp: 53–82.
    CrossRef  |  Direct Link  |  
25. Mir, M., 2023. Therapeutic potential of Cell Cycle Kinases in Breast Cancer. 1st Edn., Springer, Singapore, ISBN: 978-981-19-8911-7, pages: 373.
    CrossRef  |  Direct Link  |  
26. Lone, M.N., S. Gul, U. Mehraj, S. Sofi and A.H. Dar et al., 2023. Synthesis and biological evaluation of novel uracil derivatives as thymidylate synthase inhibitors. Appl. Biochem. Biotechnol., 10.1007/s12010-023-04367-3.
    CrossRef  |  Direct Link  |  
27. Dar, K.B., R.A. Parry, A.H. Bhat, A.H. Beigh and M. Ahmed et al., 2023. Immunomodulatory efficacy of Cousinia thomsonii C.B. Clarke in ameliorating inflammatory cascade expressions. J. Ethnopharmacol. Vol. 300. 10.1016/j.jep.2022.115727.
    CrossRef  |  Direct Link  |  
28. Alhandod, T.A., S.I. Rabbani, M. Almuqbil, S. Alshehri and S.A. Hussain et al., 2023. A systematic review on the safety and efficacy of COVID-19 vaccines approved in Saudi Arabia. Vaccines, Vol. 11. 10.3390/vaccines11020281.
    CrossRef  |  Direct Link  |  
29. Yousuf, U., S. Sofi, A. Makhdoomi and M.A. Mir, 2022. Identification and analysis of dysregulated fatty acid metabolism genes in breast cancer subtypes. Med. Oncol. Vol. 39. 10.1007/s12032-022-01861-2.
    CrossRef  |  Direct Link  |  
30. Sofi, S., U. Mehraj, H. Qayoom, S. Aisha, S.M.B. Asdaq, A. Almilaibary and M.A. Mir, 2022. Cyclin-dependent kinases in breast cancer: Expression pattern and therapeutic implications. Med. Oncol., Vol. 39. 10.1007/s12032-022-01731-x.
    CrossRef  |  Direct Link  |  
31. Sofi, S., U. Mehraj, H. Qayoom, S. Aisha, A. Almilaibary, M. Alkhanani and M.A. Mir, 2022. Targeting cyclin-dependent kinase 1 (CDK1) in cancer: Molecular docking and dynamic simulations of potential CDK1 inhibitors. Med. Oncol., Vol. 39. 10.1007/s12032-022-01748-2.
    CrossRef  |  Direct Link  |  
32. Sheikh, B.A., B.A. Sheikh, M.A. Rizvi, Z. Ahmad, A. Almilaibary, M. Alkhanani and M.A. Mir, 2022. Computational studies to identify potential inhibitors targeting the dpre1 protein in mycobacterium tuberculosis. Int. J. Pharm. Investigation. 13: 129-138.
    CrossRef  |  Direct Link  |  
33. Sheikh, B.A., B.A. Bhat, Z. Ahmad and M.A. Mir, 2022. Strategies Employed to Evade the Host Immune Response and the Mechanism of Drug Resistance in Mycobacterium tuberculosis: In Search of Finding New Targets. In: Current Pharmaceutical Biotechnology, Labrou, N. (Ed.), Bentham Science Publishers Ltd., Netherlands, pp: 1704-1720.
    CrossRef  |  Direct Link  |  
34. Sheikh, B.A., B.A. Bhat and M.A. Mir, 2022. Antimicrobial resistance: New insights and therapeutic implications. Appl. Microbiol. Biotechnol., 106: 6427-6440.
    CrossRef  |  Direct Link  |  
35. Shah,M.Z.u.h., M. Soni, V.k. Shrivastava, M.A. Mir and S. Muzamil, 2022. Gallic acid reverses ovarian disturbances in mice with letrozole-induced PCOS via modulating adipo R1 expression. Toxicol. Rep., 9: 1938-1949.
    CrossRef  |  Direct Link  |  
36. Shah, M.Z.u.h., V. Shrivastava and M.A. Mir, 2022. Metformin treatment ameliorates endocrine-metabolic disturbances in letrozole-induced PCOS mice model by modulating adiponectin status. Obesity Med., Vol. 31. 10.1016/j.obmed.2022.100392.
    CrossRef  |  Direct Link  |  
37. Qayoom, H., U. Mehraj, S. Sofi, S. Aisha, A. Almilaibary, M. Alkhanani and M.A. Mir, 2022. Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: A molecular docking and MD simulation study. Med. Oncol., Vol. 39. 10.1007/s12032-022-01779-9.
    CrossRef  |  Direct Link  |  
38. Qadri, H., A.H. Shah, S.M. Ahmad, B. Alshehri, A. Almilaibary and M.A. Mir, 2022. Natural products and their semi-synthetic derivatives against antimicrobial-resistant human pathogenic bacteria and fungi. Saudi J. Biol. Sci., Vol. 29. 10.1016/j.sjbs.2022.103376.
    CrossRef  |  Direct Link  |  
39. Qadri, H., A.H. Shah, M.A. Mir, M.F. Qureshi and R. Prasad, 2022. Quinidine drug resistance transporter knockout Candida cells modulate glucose transporter expression and accumulate metabolites leading to enhanced azole drug resistance. Fungal Genet. Biol., Vol. 161. 10.1016/j.fgb.2022.103713.
    CrossRef  |  Direct Link  |  
40. Mir. M.A., U. Jan and H. Qadri, 2022. Significance of immunotherapy for human fungal diseases and antifungal drug discovery. In: Human Pathogenic Microbes Diseases and Concerns. Mir. M.A. (Ed.)., Elsevier, Amsterdam, pp: 24.
    CrossRef  |  Direct Link  |  
41. Mir. M.A., M. Usman, H. Qadri and S. Aisha, 2022. Recent trends in the development of bacterial and fungal vaccines. In: Human Pathogenic Microbes Diseases and Concerns. Mir. M.A. (Ed.)., Elsevier Amsterdam, pp: 27.
    CrossRef  |  Direct Link  |  
42. Mir. M.A., M. Kumawat, B. Nabi and M. Kumar, 2022. Combinatorial approach to combat drug resistance in human pathogenic bacteria. In: Human Pathogenic Microbes Diseases and Concerns. Mir. M.A. (Ed.)., Elsevier, Amsterdam, pp: 20.
    CrossRef  |  Direct Link  |  
43. Mir. M.A., H. Qadri, S. Aisha and A.H. Shah, 2022. Combinatorial approach to combat drug resistance in human pathogenic fungi. In: Human Pathogenic Microbes Diseases and Concerns. Mir. M.A. (Ed.)., Elsevier, Amsterdam, pp: 26.
    CrossRef  |  Direct Link  |  
44. Mir. M.A., 2022. Index. In: Human Pathogenic Microbes Diseases and Concerns. Mir. M.A. (Ed.)., Elsevier, Amsterdam, pp: 6.
    CrossRef  |  Direct Link  |  
45. Mir,M.A., H. Qadri, S. Aisha and A.H. Shah, 2022. Combating human fungal infections. In: Human Pathogenic Microbes Diseases and Concerns. Mir, M.A. (Ed.)., Elsevier, Amsterdam, pp: 26.
    CrossRef  |  Direct Link  |  
46. Mir, W.R., B.A. Bhat, M.A. Rather, S. Muzamil, A. Almilaibary, M. Alkhanani and M.A. Mir, 2022. Molecular docking analysis and evaluation of the antimicrobial properties of the constituents of Geranium wallichianum D. Don ex sweet from Kashmir Himalaya. Sci. Rep., Vol. 12. 10.1038/s41598-022-16102-9.
    CrossRef  |  Direct Link  |  
47. Mir, M.A., W.R. Mir, B.A. Bhat, A. Almilaibary and S.M.B. Asdaq, 2022. Evaluation of the in vitro antimicrobial activities of Delphinium roylei: An insight from molecular docking and MD-simulation studies. Med. Chem., 18: 1109-1121.
    CrossRef  |  Direct Link  |  
48. Mir, M.A., U. Rasool, S. Aisha, B. Alshehri and S.S. Hamadani, 2022. Human pathogenic microbes (bacterial and fungal) and associated diseases. In: Human pathogenic microbes diseases and concerns. Manzoor Ahmad Mir, Elsevier Amsterdam, pp: 30.
    CrossRef  |  Direct Link  |  
49. Mir, M.A., U. Mehraj, H. Qayoom, S. Shafi, P. Farhana and S.M.B. Asdaq, 2022. Cryptolepine targets TOP2A and inhibits tumor cell proliferation in breast cancer
    cells-An in vitro and in silico study. Anti-Cancer Agents Med. Chem., 22: 3025-3037.
    CrossRef  |  Direct Link  |  
50. Mir, M.A., S.S. Hamdani and H. Qadri, 2022. Significance of immunotherapy for human bacterial diseases and antibacterial drug discovery. In: Human Pathogenic Microbes Diseases and Concerns. Mir, M.A. (Ed.)., Elsevier, Amsterdam, pp: 33.
    CrossRef  |  Direct Link  |  
51. Mir, M.A., S. Sofi and S. Aisha, 2022. Role of Cancer-Associated Fibroblasts in Tumor Microenvironment. In: Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies, Mir, M.A. (Ed.), Elsevier, Amsterdam, Netherlands, ISBN: 978-0-443-18696-7, pp: 59-86.
    CrossRef  |  Direct Link  |  
52. Mir, M.A., S. Sofi and H. Qayoom, 2022. The Interplay of Immunotherapy, Chemotherapy, and Targeted Therapy in Tripple Negative Breast Cancer (TNBC). In: Combinational Therapy in Triple Negative Breast Cancer, Mir, M., (Ed.), Elsevier, pp: 149-176.
    CrossRef  |  Direct Link  |  
53. Mir, M.A., S. Sofi and H. Qayoom, 2022. Targeting Biologically Specific Molecules in Triple Negative Breast Cancer (TNBC) In: Combinational Therapy in Triple Negative Breast Cancer, Mir, M., (Ed.), Elsevier, pp: 177-200.
    CrossRef  |  Direct Link  |  
54. Mir, M.A., S. Sofi and H. Qayoom, 2022. Role of Immune System in TNBC. In: Combinational Therapy in Triple Negative Breast Cancer, Mir, M., (Ed.), Elsevier, pp: 121-148.
    CrossRef  |  Direct Link  |  
55. Mir, M.A., S. Sofi and H. Qayoom, 2022. Conventional Adjuvant Chemotherapy in Combination with Surgery, Radiotherapy, and other Specific Targets. In: Combinational Therapy in Triple Negative Breast Cancer, Mir, M., (Ed.), Elsevier, pp: 95-120.
    CrossRef  |  Direct Link  |  
56. Mir, M.A., S. Aisha, S. Sofi and S. Rasheid, 2022. The Tumor Microenvironment. In: Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies, Mir, M.A. (Ed.), Elsevier, Amsterdam, Netherlands, ISBN: 978-0-443-18696-7, pp: 31-58.
    CrossRef  |  Direct Link  |  
57. Mir, M.A., S. Aisha, S. Nisar, H. Qayoom and U. Mehraj, 2022. Immuno-Onco-Metabolism and Therapeutic Resistance. In: Immuno-Oncology Crosstalk and Metabolism, Macha, M.A., A.A. Bhat and N.A. Wani, (Eds.), Springer, Singapore, ISBN: 978-981-16-6226-3, pp: 45-89.
    CrossRef  |  Direct Link  |  
58. Mir, M.A., S. Aisha, H. Qadri, U. Jan, A. Yousuf and N. Jan, 2022. Evolution of antimicrobial drug resistance in human pathogenic bacteria. In: Human Pathogenic Microbes Diseases and Concerns. Mir, M.A., (Ed.) Elsevier, Amsterdam, 22.
    CrossRef  |  Direct Link  |  
59. Mir, M.A., S. Aisha and U. Mehraj, 2022. Triple-Negative Breast Cancer - An Aggressive Subtype of Breast Cancer. In: Combinational Therapy in Triple Negative Breast Cancer, Mir, M., (Ed.), Elsevier, pp: 1-28.
    CrossRef  |  Direct Link  |  
60. Mir, M.A., S. Aisha and U. Mehraj, 2022. Novel Biomarkers in Triple-Negative Breast Cancer - Role and Perspective. In: Combinational Therapy in Triple Negative Breast Cancer, Mir, M., (Ed.), Elsevier, pp: 29-60.
    CrossRef  |  Direct Link  |  
61. Mir, M.A., S. Aisha and U. Mehraj, 2022. Different Drug Delivery Approaches in Combinational Therapy in TNBC. In: Combinational Therapy in Triple Negative Breast Cancer, Mir, M., (Ed.), Elsevier, pp: 201-230.
    CrossRef  |  Direct Link  |  
62. Mir, M.A., S. Aisha and U. Mehraj, 2022. Current Therapeutics and Treatment Options in TNBC. In: Combinational Therapy in Triple Negative Breast Cancer, Mir, M., (Ed.), Elsevier, pp: 61-94.
    CrossRef  |  Direct Link  |  
63. Mir, M.A., S. Aisha and S. Sofi, 2022. Introduction to Various Types of Cancers. In: Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies, Mir, M.A. (Ed.), Elsevier, Amsterdam, Netherlands, ISBN: 978-0-443-18696-7, pp: 1-29.
    CrossRef  |  Direct Link  |  
64. Mir, M.A., B. Mir, M. Kumawat, M. Alkhanani and U. Jan, 2022. Manipulation and exploitation of host immune system by pathogenic Mycobacterium tuberculosis for its advantage. Future Microbiol., 17: 1171-1198.
    CrossRef  |  Direct Link  |  
65. Mir, M.A., A.Y. Mir, U. Jan, M.A. Dar and M.Z.U.H. Shah, 2022. Role of mesenchymal stem cells in tumor microenvironment. In: Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies, Mir, M.A. (Ed.), Elsevier, Amsterdam, Netherlands, ISBN: 978-0-443-18696-7, pp: 87-111.
    CrossRef  |  Direct Link  |  
66. Mir, M.A., A.Y. Mir and T. Mushtaq, 2022. Role of Tumor-Associated Macrophages in the Breast Tumor Microenvironment. In: Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies, Mir, M.A. (Ed.), Elsevier, Amsterdam, Netherlands, ISBN: 978-0-443-18696-7, pp: 137-169.
    CrossRef  |  Direct Link  |  
67. Mir, M.A., 2022. Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies. Elsevier, Amsterdam, Netherlands, ISBN: 978-0-443-18696-7, Pages: 282.
    CrossRef  |  Direct Link  |  
68. Mir, M.A., 2022. Evolution of antimicrobial drug resistance in human pathogenic fungi. In: Human Pathogenic Microbes Diseases and Concerns. Mir, M.A., (Ed.) Elsevier Amsterdam, pp: 18.
    CrossRef  |  Direct Link  |  
69. Mir, M.A., 2022. Combating human bacterial infections. In: Human Pathogenic Microbes Diseases and Concerns. Mir, M.A., (Ed.)., Elsevier, Amsterdam, pp: 32.
    CrossRef  |  Direct Link  |  
70. Mir, M.A. and U. Jan, 2022. Role of Tumor-Associated Neutrophils In The Breast Tumor Microenvironment. In: Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies, Mir, M.A. (Ed.), Elsevier, Amsterdam, Netherlands, ISBN: 978-0-443-18696-7, pp: 171-194.
    CrossRef  |  Direct Link  |  
71. Mir, M.A. and B.U. Haq, 2022. Targeting Tumor Microenvironment for Breast Cancer Treatment. In: Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies, Mir, M.A. (Ed.), Academic Press, Cambridge, Massachusetts, ISBN: 978-0-443-18696-7, pp: 249-277.
    CrossRef  |  Direct Link  |  
72. Mir, M.A. and A.Y. Mir 2022. Role of Regulatory T Cells in Cancer. In: Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies, Mir, M.A. (Ed.), Elsevier, Amsterdam, Netherlands, ISBN: 978-0-443-18696-7, pp: 113-136.
    CrossRef  |  Direct Link  |  
73. Mir, M.A. and A.Q. Naik, 2022. Breast Cancer Stem Cells and their Role in Tumor Microenvironment. In: Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies, Mir, M.A. (Ed.), Elsevier, Amsterdam, Netherlands, ISBN: 978-0-443-18696-7, pp: 221-248.
    CrossRef  |  Direct Link  |  
74. Mir, M.A. and A. Gul, 2022. The Extracellular Matrix in Breast Cancer. In: Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies, Mir, M.A. (Ed.), Elsevier, Amsterdam, Netherlands, ISBN: 978-0-443-18696-7, pp: 195-220.
    CrossRef  |  Direct Link  |  
75. Mir, M.A. 2022. Synthesis and biological evaluation of novel uracil derivatives as thymidylate synthase inhibitors. Res. Square, 10.21203/rs.3.rs-2053542/v1.
    CrossRef  |  Direct Link  |  
76. Mir, M., 2022. Combinational Therapy in Triple Negative Breast Cancer. 1st Edn., Elsevier, pages: 242.
    CrossRef  |  Direct Link  |  
77. Mehraj, U., U. Mushtaq, M.A. Mir, A. Saleem and M.A. Macha, et al., 2022. Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications. Semin. Cancer Biol., 86: 769-783.
    CrossRef  |  Direct Link  |  
78. Mehraj, U., S. Aisha, S. Sofi and M.A. Mir, 2022. Expression pattern and prognostic significance of baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5) in breast cancer: A comprehensive analysis. Adv. Cancer Biol.-Metastasis, Vol. 4. 10.1016/j.adcanc.2022.100037.
    CrossRef  |  Direct Link  |  
79. Mehraj, U., N.A. Wani, A. Hamid, M. Alkhanani, A. Almilaibary and M.A. Mir, 2022. Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941. Front. Pharmacol., Vol. 13. 10.3389/fphar.2022.958443.
    CrossRef  |  Direct Link  |  
80. Mehraj, U., I.A. Mir, M.U. Hussain, M. Alkhanani, N.A. Wani and M.A. Mir, 2022. Adapalene and doxorubicin synergistically promote apoptosis of TNBC cells by hyperactivation of the ERK1/2 pathway through ROS induction. Front. Oncol., Vol. 12. 10.3389/fonc.2022.938052.
    CrossRef  |  Direct Link  |  
81. Mehraj, U., B. Alshehri, A.A. Khan, A.A. Bhat and P. Bagga et al., 2022. Expression pattern and prognostic significance of chemokines in breast cancer: An integrated bioinformatics analysis. Clin. Breast Cancer, 22: 567-578.
    CrossRef  |  Direct Link  |  
82. Bhat, B.A., W.R. Mir, B.A. Sheikh, M.A. Rather, T. ul Hassan Dar and M.A. Mir, 2022. In vitro and in silico evaluation of antimicrobial properties of Delphinium cashmerianum L., a medicinal herb growing in Kashmir, India. J. Ethnopharmacol., Vol. 291. 10.1016/j.jep.2022.115046.
    CrossRef  |  Direct Link  |  
83. Bhat, B.A., W.R. Mir, B.A. Sheikh, M. Alkanani and M.A. Mir, 2022. Metabolite fingerprinting of phytoconstituents from Fritillaria cirrhosa D. Don and molecular docking analysis of bioactive peonidin with microbial drug target proteins. Sci. Rep., Vol. 12. 10.1038/s41598-022-10796-7.
    CrossRef  |  Direct Link  |  
84. Bhat, B.A., A. Almilaibary, R.A. Mir, B.M. Aljarallah, W.R. Mir, F. Ahmad and M.A. Mir, 2022. Natural therapeutics in aid of treating Alzheimer's disease: A green gateway toward ending quest for treating neurological disorders. Front. Neurosci., Vol. 16. 10.3389/fnins.2022.884345.
    CrossRef  |  Direct Link  |  
85. Alsagaby, S.A., D. Iqbal, I. Ahmad, H. Patel and S.A. Mir et al., 2022. In silico investigations identified butyl xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia. Sci. Rep., Vol. 12. 10.1038/s41598-022-21546-0.
    CrossRef  |  Direct Link  |  
86. Sheikh, B.A., B.A. Bhat, B. Alshehri, R.A. Mir, W.R. Mir, Z.A. Parry and M.A. Mir, 2021. Nano-drug delivery systems: Possible end to the rising threats of tuberculosis. j. biomed. nanotechnol. 17: 2298-2318.
    CrossRef  |  Direct Link  |  
87. Sheikh, B.A., B.A. Bhat, B. Alshehri, R.A. Mir, W.R. Mir, Z.A. Parry and M.A. Mir, 2021. Nano-drug delivery systems: Possible end to the rising threats of tuberculosis. J. Biomed. Nanotechnol., 17: 2298-2318.
    CrossRef  |  Direct Link  |  
88. Qayoom, H., N.A. Wani, B. Alshehri and M.A. Mir, 2021. An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer. Future Oncol., 17: 4185-4206.
    CrossRef  |  Direct Link  |  
89. Qayoom, H., N.A. Wani, B. Alshehri and M.A. Mir, 2021. An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer. Future Oncol., 17: 4185-4206.
    CrossRef  |  Direct Link  |  
90. Qadri, H., M.F. Qureshi, M.A. Mir and A.H. Shah, 2021. Glucose - The X factor for the survival of human fungal pathogens and disease progression in the host. Microbiol. Res. Vol. 247. 10.1016/j.micres.2021.126725.
    CrossRef  |  Direct Link  |  
91. Qadri, H., A.H. Shah and M. Mir, 2021. Novel Strategies to Combat the Emerging Drug Resistance in Human Pathogenic Microbes. In: Current Drug Targets, Castellino, F.J. (Ed.), Bentham Science Publishers Ltd., Netherlands, pp: 1424-1436.
    CrossRef  |  Direct Link  |  
92. Mir, M.A., B.A. Bhat, B.A. Sheikh, G.A. Rather, S. Mehraj and W.R. Mir, 2021. Nanomedicine in Human Health Therapeutics and Drug Delivery. In: Applications of Nanomaterials in Agriculture, Food Science, and Medicine, Bhat, M.A., I.A. Wani and S. Ashraf (Eds.), IGI Global, Hershey, Pennsylvania, ISBN-13: 9781799855637, Pages: 23.
    CrossRef  |  Direct Link  |  
93. Mir, M.A., 2021. Combination Therapies and their Effectiveness in Breast Cancer Treatment. Nova Science Publishers, Hauppauge, New York, ISBN: 9781685072476, Pages: 429.
    CrossRef  |  Direct Link  |  
94. Mir, M.A., 2021. Combination Therapies and their Effectiveness in Breast Cancer Treatment. Nova Science Publishers, Hauppauge, New York, ISBN: 978-1-68507-195-0, Pages: 411.
    CrossRef  |  Direct Link  |  
95. Mehraj, U., R.A. Ganai, M.A. Macha, A. Hamid and M.A. Zargar, 2021. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities. Cell. Oncol., 44: 1209-1229.
    CrossRef  |  Direct Link  |  
96. Mehraj, U., H. Qayoom and M.A. Mir, 2021. Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives. Breast Cancer, 28: 539-555.
    CrossRef  |  Direct Link  |  
97. Mehraj, U., A.H. Dar, N.A. Wani and M.A. Mir, 2021. Tumor microenvironment promotes breast cancer chemoresistance. Cancer Chemother. Pharmacol., 87: 147-158.
    CrossRef  |  Direct Link  |  
98. Majeed, M., T.B. Pirzadah, M.A. Mir, K.R. Hakeem and H.F. Alharbyet al., 2021. Comparative study on phytochemical profile and antioxidant activity of an epiphyte, viscum album l. (white berry mistletoe), derived from different host trees. Plants, Vol. 10. 10.3390/plants10061191.
    CrossRef  |  Direct Link  |  
99. Bhat, B.A., S. Nisar, B.A. Sheikh, W.R. Mir and M.A. Mir, 2021. Antioxidants (Natural and Synthetic) Screening Assays: An Overview. In: Bentham Briefs in Biomedicine and Pharmacotherapy Oxidative Stress and Natural Antioxidants, Kaur, P., R.G. Mehta, Robin, T.S. Thind and S. Arora (Eds.), Bentham Science Publishers, Netherlands, Europe, ISBN: 978-981-4998-88-8, pp: 105-126.
    CrossRef  |  Direct Link  |  
100. Sheikh, B.A., B.A. Bhat, U. Mehraj, W. Mir, S. Hamadani and M.A. Mir, 2020. Development of new therapeutics to meet the current challenge of drug resistant tuberculosis. Current Pharm. Biotechnol., 22: 480-500.
     CrossRef  |  Direct Link  |  
101. Mir, M.A., U. Mehraj, B.A. Sheikh and S.S. Hamdani, 2020. Nanobodies: The “Magic Bullets” in therapeutics, drug delivery and diagnostics. Hum. Antibodies, 28: 29-51.
     CrossRef  |  Direct Link  |  
102. Mir, M.A., U. Mehraj and B.A. Sheikh, 2020. Recent advances in chemotherapeutic implications of deguelin: a plant- derived retinoid. Nat. Prod. J., 11: 169-181.
     CrossRef  |  Direct Link  |  
103. Mir, M.A., H. Qayoom, U. Mehraj, S. Nisar, B. Bhat and N.A. Wani, 2020. Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast Cancer. In: Current Cancer Drug Targets, Zhang, R. (Ed.), Bentham Science Publishers Ltd., USA, pp: 586-602.
     CrossRef  |  Direct Link  |  
104. Mir, M.A., 2020. The Fundamentals of Hypersensitivities and Allergies. Nova Science Publishers, Hauppauge, New York, USA, ISBN: 978-1-53617-012-2, Pages: 248.
     CrossRef  |  Direct Link  |  
105. Mir, M.A., 2020. Basics and Fundamentals of Immunology. Nova Science Publishers, Hauppauge, New York, USA, ISBN: 978-1-53616-639-2, Pages: 336.
     CrossRef  |  Direct Link  |  
106. Mir, M.A., 2020. Immunoglobulins, Magic Bullets and Therapeutic Antibodies. Nova Science Publishers, Hauppauge, New York, ISBN: 978-1-53616-903-4, Page: 322.
     CrossRef  |  Direct Link  |  
107. Mir, M.A., 2020. Cytokines and Their Therapeutic Potential. Nova Science Publishers, Hauppauge, New York, USA, ISBN: 978-1-53617-017-7, Pages: 168.
     CrossRef  |  Direct Link  |  
108. Mir, M.A., S.S. Hamdani, B.A. Sheikh and U. Mehraj, 2019. Recent Advances in Metabolites from Medicinal Plants in Cancer Prevention and Treatment. In: Current Immunology Reviews (Discontinued), Czerkinsky, C. (Ed.), Bentham Science Publishers Ltd., USA, pp: 185-201.
     CrossRef  |  Direct Link  |  
109. Mir, M.A. and U. Mehraj, 2019. Double-crosser of the Immune System: Macrophages in Tumor Progression and Metastasis. In: Current Immunology Reviews (Discontinued), Czerkinsky, C. (Ed.), Bentham Science Publishers Ltd., Netherlands, pp: 172-184.
     CrossRef  |  Direct Link  |  
110. Mir, M.A., N. Shabir, U. Mehraj, Y.M. Rather and S. Farhat, 2018. Study on the quality control analysis of antiepileptic drugs using high-performance liquid chromatography. Int. J. Pharma. Investig., 8: 115-121.
     CrossRef  |  Direct Link  |  
111. Hafeez, S., M. Urooj, S. Saleem, Z. Gillani and S. Shaheen et al., 2016. BAD, a proapoptotic protein, escapes ERK/RSK phosphorylation in deguelin and siRNA-treated HeLa cells. PLoS ONE, Vol. 11. 10.1371/journal.pone.0145780.
     CrossRef  |  Direct Link  |  
112. Mir, M.A., 2015. T-Cell Costimulation and Its Applications in Diseases. In: Developing Costimulatory Molecules for Immunotherapy of Diseases, Mir, M.A. (Ed.), Elsevier Academic Press, Amsterdam, London, UK, ISBN: 978-0-12-802585-7, pp: 255-292.
     CrossRef  |  Direct Link  |  
113. Mir, M.A., 2015. Introduction to Costimulation and Costimulatory Molecules. In: Developing Costimulatory Molecules for Immunotherapy of Diseases, Mir, M.A. (Ed.), Elsevier Academic Press, Amsterdam, London, UK, ISBN: 978-0-12-802585-7, pp: 1-43.
     CrossRef  |  Direct Link  |  
114. Mir, M.A., 2015. Costimulation in Lymphomas and Cancers. In: Developing Costimulatory Molecules for Immunotherapy of Diseases, Mir, M.A. (Ed.), Elsevier Academic Press, Amsterdam, London, UK, ISBN: 978-0-12-802585-7, pp: 185-254.
     CrossRef  |  Direct Link  |  
115. Mir, M.A., 2015. Costimulation Immunotherapy in Infectious Diseases. In: Developing Costimulatory Molecules for Immunotherapy of Diseases, Mir, M.A. (Ed.), Elsevier Academic Press, Amsterdam, London, UK, ISBN: 978-0-12-802585-7 pp: 83-129.
     CrossRef  |  Direct Link  |  
116. Mir, M.A., 2015. Costimulation Immunotherapy in Allergies and Asthma. In: Developing Costimulatory Molecules for Immunotherapy of Diseases, Mir, M.A. (Ed.), Elsevier Academic Press, Amsterdam, London, UK, ISBN: 978-0-12-802585-7, pp: 131-184.
     CrossRef  |  Direct Link  |  
117. Mir, M.A., 2015. Concept of Reverse Costimulation and Its Role in Diseases. In: Developing Costimulatory Molecules for Immunotherapy of Diseases, Mir, M.A. (Ed.), Elsevier Academic Press, Amsterdam, London, UK, ISBN: 978-0-12-802585-7, pp: 45-81.
     CrossRef  |  Direct Link  |  
118. Mir, M.A. and R.S. Albaradie, 2015. Immunomodulation of inflammatory markers in activated macrophages by leaf extracts of Gingko biloba. Adv. Neuroimmune Biol., 6: 9-17.
     CrossRef  |  Direct Link  |  
119. Garriga, M., M. MilË, M. Mir, R. Al-Baradie and S. Huertas et al., 2015. 123I-FP-CIT SPECT imaging in early diagnosis of dementia in patients with and without a vascular component. Front. Syst. Neurosci., Vol. 9. 10.3389/fnsys.2015.00099.
     CrossRef  |  Direct Link  |  
120. Mir, M.A. and R.S. Albaradie, 2014. Inflammatory mechanisms as potential therapeutic targets in stroke. Adv. Neuroimmune Biol., 5: 199-216.
     CrossRef  |  Direct Link  |  
121. Mir, M.A. and R. Al-Baradie, 2013. Tuberculosis timebomb a global emergency : Need for alternative vaccines. Majmaah J. Health Sci., 1: 77-82.
     CrossRef  |  Direct Link  |  
122. Mir, M.A. and J.N. Agrewala, 2008. Signaling through CD80: An approach for treating lymphomas. Expert Opin. Ther. Targets, 12: 969-979.
     CrossRef  |  Direct Link  |  
123. Mir, M.A. and J.N. Agrewala, 2007. Influence of CD80 and CD86 Co-Stimulation in the Modulation of the Activation of Antigen Presenting Cells. In: Current Immunology Reviews (Discontinued), Czerkinsky, C. (Ed.), Bentham Science Publishers Ltd., Netherlands, pp: 160-169.
     CrossRef  |  Direct Link  |